Skip to main content

Table 8 Impact of treatments on willingness to recommend COVID-19 vaccines (OLS): Extended controls

From: How (not) to mobilize health workers in the fight against vaccine hesitancy: Experimental evidence from Germany’s AstraZeneca controversy

Parameter

AZ

J & J

Moderna

Pfizer

Sinopharm

Sputnik-V

 

(1)

(2)

(3)

(4)

(5)

(6)

T1: Scientific AZ debate

-0.683

-0.329

-0.111

0.080

-0.504

-0.332

 

(0.134)***

(0.130)**

(0.104)

(0.065)

(0.146)***

(0.141)**

T2: Misinformation

0.037

0.162

0.076

0.023

0.423

0.277

 

(0.130)

(0.124)

(0.099)

(0.065)

(0.155)***

(0.140)**

T3: Own health

0.087

0.112

0.016

0.037

0.151

0.178

 

(0.127)

(0.124)

(0.100)

(0.064)

(0.153)

(0.140)

T4: Public health

0.075

0.095

0.022

-0.002

0.162

0.288

 

(0.128)

(0.124)

(0.098)

(0.065)

(0.152)

(0.140)**

Observations

3,276

3,276

3,276

3,276

3,276

3,276

r2

0.8167

0.8169

0.9134

0.9702

0.6131

0.7141

meanT0End

4.9624

4.7207

5.8669

6.6136

3.3068

3.8770

T1vsT2

0.0000

0.0002

0.0745

0.3902

0.0000

0.0000

T1vsT3

0.0000

0.0007

0.2301

0.5087

0.0000

0.0003

T1vsT4

0.0000

0.0010

0.1990

0.2158

0.0000

0.0000

T2vsT3

0.6956

0.6845

0.5489

0.8295

0.0807

0.4805

T2vsT4

0.7723

0.5892

0.5879

0.7082

0.0922

0.9358

T3vsT4

0.9208

0.8929

0.9476

0.5508

0.9462

0.4310

State FE

Yes

Yes

Yes

Yes

Yes

Yes

Basic Controls

Yes

Yes

Yes

Yes

Yes

Yes

Extended Controls

Yes

Yes

Yes

Yes

Yes

Yes

  1. Notes: ‘AZ’ refers to AstraZeneca, ‘J & J’ refers to Johnson & Johnson, and ‘Pfizer’ refers to Pfizer/BioNTech. State FE include controls for respondents place of residence (state). Basic controls include respondent’s age, gender, education, and survey specifics (order of vaccine-related questions, platform, device). Extended controls refers to additional controls on respondent’s preferences (risk, patience, altruism) and whether she/he had ever been diagnosed with Covid. Robust standard errors used. Standard errors are in parentheses. */**/*** denotes 10/5/1 percent significance levels